BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Tg Therapeutics Inc.

Headquarters: New York, NY, United States of America
Year Founded: 2012
Status: Public
Industry Sector: HealthTechnology
CEO: Michael Sean Weiss
Number Of Employees: 338
Enterprise Value: $4,768,834,135
PE Ratio: 288.68
Exchange/Ticker 1: NASDAQ:TGTX
Exchange/Ticker 2: N/A
Latest Market Cap: $6,329,961,472